Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Regulation of Compounding Pharmacies
David G. Miller, RPh, discusses whether and how regulation of compounding pharmacies needs to change.
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses whether and how regulation of compounding pharmacies needs to change in the wake of the meningitis outbreak caused by tainted steroids produced by the New England Compounding Center.
Related Videos
Related Content
